Histomorphometric analysis of the lung of Swiss mice treated with a fibrinolytic protease

Abstract Fibrinolytic enzymes are considered promising alternative in the treatment of cardiovascular diseases by preventing fibrin clots. A protease from Mucor subtilissimus UCP 1262 was obtained by solid state fermentation and purified by ion exchange chromatography. The purified extract was admin...

Full description

Saved in:
Bibliographic Details
Published inAnais da Academia Brasileira de Ciências Vol. 94; no. 4; p. e20201914
Main Authors SILVA, MARLLYN M. DA, LIRA, MARIA A.C. DE, ROCHA, TAMIRIS A., MOURA, DANIELLE F. DE, C.A.A. JÚNIOR, FRANCISCO, FERREIRA, ANA V.S., PASTRANA, LORENZO, ALBUQUERQUE, WENDELL W.C., COSTA, ROMERO M.P.B., NASCIMENTO, THIAGO P., PORTO, ANA L.F.
Format Journal Article
LanguageEnglish
Portuguese
Published Academia Brasileira de Ciências 01.01.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Fibrinolytic enzymes are considered promising alternative in the treatment of cardiovascular diseases by preventing fibrin clots. A protease from Mucor subtilissimus UCP 1262 was obtained by solid state fermentation and purified by ion exchange chromatography. The purified extract was administered at an acute dose of 2000 mg/mL to evaluate its toxic effects to the lungs of mice. After 14 days of treatment, a histomorphometric study was performed by the type 1 and 2 pneumocyte count and the evaluation of the lung area. As result, the experimental group showed a significant decrease of type 2 pneumocyte and although a decrease in the alveolar area was observed in relation to the control group, no significant pulmonary toxicity, emphysema, and fibrosis characteristics were detected. The in vitro tests suggest possible clinical applications for the enzyme.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0001-3765
1678-2690
1678-2690
DOI:10.1590/0001-3765202220201914